November 12, 2026 · Journal of the American College of Cardiology · DOI: 10.1016/j.jacc.2026.09.018

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: Navigating Heterogeneity in Clinical Evidence: JACC Evidence Review.

Listen to this summary

This JACC Evidence Review asks whether the recent randomized trials of left atrial appendage closure (LAAC; OPTION, CLOSURE-AF, CHAMPION-AF, and others) can be pooled into a single estimate of LAAC versus anticoagulation for stroke prevention in atrial fibrillation. The authors conclude that these trials differ too much in patient phenotype, comparator, device generation, antithrombotic regimens, endpoint construction, and follow-up to form one coherent evidence base, so pooled estimates may not apply to a common patient group. They therefore recommend anticoagulation as first-line for most eligible patients, with LAAC reserved for those in whom long-term anticoagulation is unsafe or unsustainable, guided by shared decision-making.

Behnood Bikdeli, Adith S Arun, Shubhadarshini Pawar, Sanket S Dhruva, Neel M Butala, Celina Yong, Erica S Spatz, David J Cohen, John A Bittl, Christine M Albert, Martin B Leon, Raj R Makkar, Saman Nazarian, Harlan M Krumholz, Aakriti Gupta

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play